Editas Medicine, Inc. (EDIT) Operating cash flow 2016–2025
Editas Medicine, Inc. (EDIT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$165.2MFY2025 · since FY2016: -$50.2M → -$165.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$165.2M | +21.4% |
| FY2024 | -$210.3M | -59.1% |
| FY2023 | -$132.2M | +25.5% |
| FY2022 | -$177.3M | -8.3% |
| FY2021 | -$163.8M | +8.9% |
| FY2020 | -$179.8M | -342.2% |
| FY2019 | -$40.7M | +11.0% |
| FY2018 | -$45.7M | -385.4% |
| FY2017 | -$9.4M | +81.3% |
| FY2016 | -$50.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice